High-dose Prednisone in Duchenne Muscular Dystrophy

Completed · Phase 3

Conditions studied: Duchenne Muscular Dystrophy

In brief

This study will help to determine whether a high-dose weekly course of prednisone therapy is safer than and at least as effective as daily dose therapy for people with Duchenne muscular dystrophy (DMD). Boys who are enrolled in this study should not have taken carnitine, other amino acids, creatine, glutamine, Coenzyme Q10 or any herbal medicines within the last three months. There will be a two-visit screening to take place in one week to ensure a reproducible manual muscle test. The subject will then be randomized and put into either the daily or weekly regimen. The duration of the study is twelve 28-day treatment cycles (approximately 12 months) with follow-up visits at month one, three and then every three months.

Key facts

Study ID
NCT00110669
Run by
Cooperative International Neuromuscular Research Group
People needed
64
Starts
2004-01-01
Expected to finish
2008-02-01
Last updated by the study team
2011-10-27

Who can join

Age: 4 and older, up to 10. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.